The Effect of Diabetes Mellitus on Costs and Length of Stay in Patients with Peripheral Arterial Disease Undergoing Vascular Surgery

被引:45
|
作者
Malone, M. [1 ,2 ]
Lau, N. S. [2 ,3 ]
White, J. [1 ,2 ]
Novak, A.
Xuan, W. [2 ]
Iliopoulos, J. [2 ,4 ]
Crozier, J. [2 ,4 ]
Dickson, H. G. [2 ,5 ]
机构
[1] Liverpool Hosp, High Risk Foot Serv, Liverpool, NSW 2170, Australia
[2] Ingham Inst Appl Med Res, LIVE DIAB CRU, Liverpool, NSW, Australia
[3] Liverpool Hosp, Diabet & Endocrine Serv, Liverpool, NSW 2170, Australia
[4] Western Hlth, Diabet Foot Serv, Melbourne, Vic, Australia
[5] Liverpool Hosp, Liverpool, NSW 2170, Australia
关键词
Diabetes mellitus; Economics; Length of stay; Lower limb; Peripheral arterial disease; Vascular surgery; PREVALENCE; CARE; HYPERGLYCEMIA;
D O I
10.1016/j.ejvs.2014.07.001
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: To determine the impact of diabetes mellitus (DM) and other comorbidities on length of stay (LOS) and costs in patients with peripheral arterial disease (PAD) admitted to a vascular surgical unit. Methods: A retrospective study was conducted between January 2011 and July 2012 at a tertiary referral hospital in Sydney. Demographic, laboratory, and operative data were obtained from the Australasian Vascular Audit database and hospital diagnostic-related group (DRG) reports. Patients with confirmed PAD with or without DM requiring hospital admission for a diagnosis of claudication, rest pain, ulcer/gangrene, and infection that required lower limb surgical intervention were included. Associations between LOS, surgical procedure, and DRG were explored. Results: Five hundred and sixty-eight admissions (492 patients) were identified: 292 admissions with PAD and 276 admissions with PAD in conjunction with DM (PADDM). Mean LOS for patients with PAD was 10 +/- 13.7 days compared with 15 +/- 8.2 days for PADDM (p<.01; 95% confidence interval 2.7-8.0). LOS and costs were greatest in patients with PADDM undergoing major amputation (37 +/- 3.7 days; US$42,236; p<.01). Analysis of variance indicated that the best predictors of LOS were the presence of DM, bypass surgery, amputation, chronic kidney disease (CKD) stage V, infection, and emergency admission. Over 18 months, the estimated total inpatient costs associated with lower limb intervention for PAD with and without DM amounted to US$7,598,597. People with DM incurred greater inpatient costs, averaging US$1,912 more per episode of admission and a total of US$528,029 over 18 months. Conclusion: The impact of diabetes as a comorbid condition in patients with PAD is significant, both clinically and economically. Factors that predict increased LOS in patients with PAD are DM, bypass surgery, amputation, CKD stage V, infection, and emergency admission. (C) 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:447 / 451
页数:5
相关论文
共 50 条
  • [1] The significance of peripheral arterial disease in patients with diabetes mellitus
    Diehm, C.
    Schwertfeger, M.
    Kirch, W.
    Pittrow, D.
    DIABETOLOGE, 2009, 5 (01): : 12 - 18
  • [2] Peripheral Arterial Diseases and Diabetes Mellitus: Associations With Quality of Health Measures in Patients Undergoing Percutaneous Vascular Interventions
    Haque, Mahfujul Z.
    Reesha, Syeda
    Khan, Shahrin
    Rafique, Rumyah
    Saleem, Abdulmalik
    Ilyas, Omar
    Abdullah, Luqman
    Hussain, Arif
    Husain, Mashkur
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2023, 48 : 34 - 38
  • [3] Peripheral Arterial Disease in Patients with Type 2 Diabetes Mellitus
    Dobrica, Elena-Codruta
    Cozma, Matei Alexandru
    Gaman, Mihnea-Alexandru
    Gaman, Amelia Maria
    Stanescu, Ana Maria Alexandra
    Iancu, Adela Mihaela
    Motofei, Ion
    Diaconu, Camelia Cristina
    PROCEEDINGS OF THE 35TH BALKAN MEDICAL WEEK, 2018, : 42 - 47
  • [4] Peripheral Arterial Disease in Patients with Type 2 Diabetes Mellitus
    Rhee, Sang Youl
    Kim, Young Seol
    DIABETES & METABOLISM JOURNAL, 2015, 39 (04) : 283 - 290
  • [5] LONG-TERM CURATIVE EFFECT OF PERIPHERAL ANGIOPLASTY IN PATIENTS WITH DIABETES MELLITUS AND PERIPHERAL ARTERIAL DISEASE
    Li Yingsha
    Zhao, Zhigang
    Chang, Le
    Zhu, Zhiming
    Yan, Zhencheng
    JOURNAL OF HYPERTENSION, 2018, 36 : E124 - E124
  • [6] Pathophysiology of peripheral arterial disease in diabetes mellitus
    Yang, Shao-ling
    Zhu, Lv-yun
    Han, Rui
    Sun, Lei-lei
    Li, Jun-xia
    Dou, Jing-tao
    JOURNAL OF DIABETES, 2017, 9 (02) : 133 - 140
  • [7] Sarcopenia, peripheral neuropathy, and peripheral arterial disease in patients with diabetes mellitus under hemodialysis
    Bustamante Hernandez, Martha Beatriz
    Garduno Garcia, Jose de Jesus
    Montenegro Morales, Laura Patricia
    Camarillo Romero, Eneida del Socorro
    Huitron Bravo, Gerardo
    Camarillo Romero, Maria del Socorro
    REVISTA DE NEFROLOGIA DIALISIS Y TRASPLANTE, 2021, 41 (03): : 151 - 158
  • [8] Peripheral arterial disease in diabetes mellitus
    Schmitt, Volker H.
    Keller, Karsten
    Espinola-Klein, Christine
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2022, 147 (22) : 1433 - 1436
  • [9] Clinical factors associated with ultrashort length of stay in patients undergoing lower extremity bypass for peripheral arterial disease
    Radomski, Shannon N.
    Sorber, Rebecca
    Canner, Joseph K.
    Holscher, Courtenay M.
    Weaver, M. Libby
    Hicks, Caitlin W.
    Reifsnyder, Thomas
    JOURNAL OF VASCULAR SURGERY, 2024, 80 (04)
  • [10] Characteristics and Outcomes of Patients With Diabetes Mellitus Undergoing Peripheral Vascular Intervention for Infrainguinal Symptomatic Peripheral Artery Disease
    Weissler, E. Hope
    Narcisse, Dennis, I
    Rymer, Jennifer A.
    Armstrong, Ehrin J.
    Secemsky, Eric
    Gray, William A.
    Mustapha, Jihad A.
    Adams, George L.
    Ansel, Gary M.
    Patel, Manesh R.
    Jones, W. Schuyler
    VASCULAR AND ENDOVASCULAR SURGERY, 2021, 55 (02) : 124 - 134